|
| Exchange Disseminated Time 07/05/2018 12:01:47 | Alembic Pharmaceuticals Ltd has informed BSE that a Meeting of Board of Directors of the Company shall be held on May 16, 2018, inter alia, to transact the following business:
1. To consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2018.
2. To consider and recommend dividend on Equity Shares, if any, for the financial year ended March 31, 2018.
The trading window shall remain closed from May 13, 2018 to May 18, 2018 for the above referred purpose. |
|
|